119 related articles for article (PubMed ID: 2085886)
1. Synthesis and antitumor activity of fused quinoline derivatives.
Yamato M; Takeuchi Y; Chang MR; Hashigaki K; Tsuruo T; Tashiro T; Tsukagoshi S
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3048-52. PubMed ID: 2085886
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1.
Yamato M; Takeuchi Y; Hashigaki K; Ikeda Y; Chang MR; Takeuchi K; Matsushima M; Tsuruo T; Tashiro T; Tsukagoshi S
J Med Chem; 1989 Jun; 32(6):1295-300. PubMed ID: 2542558
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of fused quinoline derivatives. IV. Novel 11-aminoindolo[3,2-b]quinolines.
Takeuchi Y; Oda T; Chang MR; Okamoto Y; Ono J; Oda Y; Harada K; Hashigaki K; Yamato M
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):406-11. PubMed ID: 9118455
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
Helissey P; Cros S; Giorgi-Renault S
Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines.
Yamato M; Takeuchi Y; Chang MR; Hashigaki K
Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):528-30. PubMed ID: 1606653
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides.
Atwell GJ; Bos CD; Baguley BC; Denny WA
J Med Chem; 1988 May; 31(5):1048-52. PubMed ID: 3361574
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Yamato M
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1629-31. PubMed ID: 1934189
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
[TBL] [Abstract][Full Text] [Related]
13. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.
Palluotto F; Sosic A; Pinato O; Zoidis G; Catto M; Sissi C; Gatto B; Carotti A
Eur J Med Chem; 2016 Nov; 123():704-717. PubMed ID: 27521587
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents.
Sharma V; Mehta DK; Das R
Mini Rev Med Chem; 2017; 17(16):1557-1572. PubMed ID: 28494729
[TBL] [Abstract][Full Text] [Related]
15. Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as "minimal" DNA-intercalating antitumor agents with in vivo solid tumor activity.
Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1989 Feb; 32(2):396-401. PubMed ID: 2913299
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of potential antitumor agents: nitrogen mustards based on quinoline].
Pellerano C; Savini L
Farmaco Sci; 1984 Aug; 39(8):681-5. PubMed ID: 6479326
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and In Vitro Antiproliferative Activity of 11-Substituted Neocryptolepines with a Branched ω-Aminoalkylamino Chain.
Shaban E; Świtalska M; Wang L; Wang N; Xiu F; Hayashi I; Ngoc TA; Nagae S; El-Ghlban S; Shimoda S; Gokha AAAE; Sayed IETE; Wietrzyk J; Inokuchi T
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137152
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents.
Jafari F; Baghayi H; Lavaee P; Hadizadeh F; Soltani F; Moallemzadeh H; Mirzaei S; Aboutorabzadeh SM; Ghodsi R
Eur J Med Chem; 2019 Feb; 164():292-303. PubMed ID: 30599418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
